"Atrial fibrillation is associated with significantly greater rates of morbidity and mortality, caused primarily by thromboembolic complications. The prevention of thromboembolic strokes is therefore one of the most important elements of the complex treatment of atrial fibrillation. Different strategies for anticoagulant or antiplatelet therapy in patients with atrial fibrillation are recommended for the prevention of thromboembolic complications according to the presentation of a different number of risk factors. New guidelines optimize antithrombotic treatment according to new risk stratification (CHA2DS2Vasc score) and mentioned the future of alternative antithrombotic treatment using direct thrombin antagonists or factor Xa inhibitors."@cs . "Antithrombotic treatment from the point of view of new guidelines for the management of atrial fibrillation"@en . "Antitrombotick\u00E1 l\u00E9\u010Dba z pohledu nov\u00FDch doporu\u010Den\u00ED pro l\u00E9\u010Dbu nemocn\u00FDch s fibrilac\u00ED s\u00EDn\u00ED" . . "Antitrombotick\u00E1 l\u00E9\u010Dba z pohledu nov\u00FDch doporu\u010Den\u00ED pro l\u00E9\u010Dbu nemocn\u00FDch s fibrilac\u00ED s\u00EDn\u00ED"@cs . "CZ - \u010Cesk\u00E1 republika" . . . . "Moravec, Ond\u0159ej" . "5"^^ . "Ondru\u0161kov\u00E1, Jana" . "Antitrombotick\u00E1 l\u00E9\u010Dba z pohledu nov\u00FDch doporu\u010Den\u00ED pro l\u00E9\u010Dbu nemocn\u00FDch s fibrilac\u00ED s\u00EDn\u00ED"@cs . "I" . "Kardiologick\u00E1 revue" . "P\u0159e\u010Dek, Jan" . "[4D467F2F04B2]" . . . "186506" . "13" . "5"^^ . "Heinc, Petr" . "T\u00E1borsk\u00FD, Milo\u0161" . "3" . . . "1212-4540" . . . . . . "RIV/00098892:_____/11:#0000185" . . . "antithrombotic treatment , guidelines, atrial fibrillation"@en . "Atrial fibrillation is associated with significantly greater rates of morbidity and mortality, caused primarily by thromboembolic complications. The prevention of thromboembolic strokes is therefore one of the most important elements of the complex treatment of atrial fibrillation. Different strategies for anticoagulant or antiplatelet therapy in patients with atrial fibrillation are recommended for the prevention of thromboembolic complications according to the presentation of a different number of risk factors. New guidelines optimize antithrombotic treatment according to new risk stratification (CHA2DS2Vasc score) and mentioned the future of alternative antithrombotic treatment using direct thrombin antagonists or factor Xa inhibitors." . "Antithrombotic treatment from the point of view of new guidelines for the management of atrial fibrillation"@en . "Atrial fibrillation is associated with significantly greater rates of morbidity and mortality, caused primarily by thromboembolic complications. The prevention of thromboembolic strokes is therefore one of the most important elements of the complex treatment of atrial fibrillation. Different strategies for anticoagulant or antiplatelet therapy in patients with atrial fibrillation are recommended for the prevention of thromboembolic complications according to the presentation of a different number of risk factors. New guidelines optimize antithrombotic treatment according to new risk stratification (CHA2DS2Vasc score) and mentioned the future of alternative antithrombotic treatment using direct thrombin antagonists or factor Xa inhibitors."@en . . "7"^^ . "Antitrombotick\u00E1 l\u00E9\u010Dba z pohledu nov\u00FDch doporu\u010Den\u00ED pro l\u00E9\u010Dbu nemocn\u00FDch s fibrilac\u00ED s\u00EDn\u00ED" . . . "RIV/00098892:_____/11:#0000185!RIV12-MZ0-00098892" . .